Corrigendum to “Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer” [Canc. Lett. 374 (2016) 292–303, (S0304383516301008), (10.1016/j.canlet.2016.02.032)];Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer

Cancer Letters

Volumn 374, Issue 2, 2016, Pages 292-303

  Yong, Xin ^a   Tang, Bo ^a   Xiao, Yu Feng ^a   Xie, Rui ^a   Qin, Yong ^a   Luo, Gang ^a   Hu, Chang Jiang ^a   Dong, Hui ^a,b   Yang, Shi Ming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Gastric cancer; Helicobacter pylori; Nanog; Oct4; Wnt catenin

Indexed keywords

BETA CATENIN; CAGA PROTEIN; G PROTEIN COUPLED RECEPTOR; HERMES ANTIGEN; LEUCINE RICH REPEAT CONTAINING G PROTEIN COUPLED RECEPTOR 5; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN KINASE B; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI; CTNNB1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; NANOG PROTEIN, HUMAN; POU5F1 PROTEIN, HUMAN;

ARTICLE; CANCER STEM CELL; CELL NUCLEUS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; GASTRIC CANCER CELL LINE; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; STOMACH CANCER; TRANSCRIPTION INITIATION; WNT SIGNALING PATHWAY; GENETICS; HELICOBACTER INFECTION; METABOLISM; MICROBIOLOGY; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; UPREGULATION;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BETA CATENIN; CELL LINE, TUMOR; CELL NUCLEUS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOMEODOMAIN PROTEINS; HUMANS; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION; WNT SIGNALING PATHWAY;

EID: 84959318433     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2022.215961     Document Type: Erratum

References (54)

1. Torre L.A., Bray F., Siegel R.L., Ferlay J., Lortet-Tieulent J., Jemal A. Global cancer statistics. CA Cancer J. Clin 2012, 65(2015):87-108.
2. Plummer M., Franceschi S., Vignat J., Forman D., de Martel C. Global burden of gastric cancer attributable to Helicobacter pylori. Int. J. Cancer 2015, 136:487-490.
3. Huang J.Q., Zheng G.F., Sumanac K., Irvine E.J., Hunt R.H. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 2003, 125:1636-1644.
4. Matos J.I., de Sousa H.A., Marcos-Pinto R., Dinis-Ribeiro M. Helicobacter pylori CagA and VacA genotypes and gastric phenotype: a meta-analysis. Eur. J. Gastroenterol. Hepatol 2013, 25:1431-1441.
5. Ohnishi N., Yuasa H., Tanaka S., Sawa H., Miura M., Matsui A., et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:1003-1008.
6. Hayashi T., Senda M., Morohashi H., Higashi H., Horio M., Kashiba Y., et al. Tertiary structure-function analysis reveals the pathogenic signaling potentiation mechanism of Helicobacter pylori oncogenic effector CagA. Cell Host Microbe 2012, 12:20-33.
7. Kwok T., Zabler D., Urman S., Rohde M., Hartig R., Wessler S., et al. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature 2007, 449:862-866.
8. Jimenez-Soto L.F., Kutter S., Sewald X., Ertl C., Weiss E., Kapp U., et al. Helicobacter pylori type IV secretion apparatus exploits beta1 integrin in a novel RGD-independent manner. PLoS Pathog 2009, 5:e1000684.
9. Kaplan-Turkoz B., Jimenez-Soto L.F., Dian C., Ertl C., Remaut H., Louche A., et al. Structural insights into Helicobacter pylori oncoprotein CagA interaction with beta1 integrin. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:14640-14645.
10. Murata-Kamiya N., Kikuchi K., Hayashi T., Higashi H., Hatakeyama M. Helicobacter pylori exploits host membrane phosphatidylserine for delivery, localization, and pathophysiological action of the CagA oncoprotein. Cell Host Microbe 2010, 7:399-411.
11. Murata-Kamiya N., Kurashima Y., Teishikata Y., Yamahashi Y., Saito Y., Higashi H., et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 2007, 26:4617-4626.
12. Lee D.G., Kim H.S., Lee Y.S., Kim S., Cha S.Y., Ota I., et al. Helicobacter pylori CagA promotes Snail-mediated epithelial-mesenchymal transition by reducing GSK-3 activity. Nat. Commun 2014, 5:4423.
13. Churin Y., Al-Ghoul L., Kepp O., Meyer T.F., Birchmeier W., Naumann M. Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J. Cell Biol 2003, 161:249-255.
14. Yong X., Tang B., Li B.S., Xie R., Hu C.J., Luo G., et al. Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways. Cell Commun. Signal 2015, 13:30.
15. Holland J.D., Klaus A., Garratt A.N., Birchmeier W. Wnt signaling in stem and cancer stem cells. Curr. Opin. Cell Biol 2013, 25:254-264.
16. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
17. Takaishi S., Okumura T., Tu S., Wang S.S., Shibata W., Vigneshwaran R., et al. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009, 27:1006-1020.
18. Soutto M., Peng D., Katsha A., Chen Z., Piazuelo M.B., Washington M.K., et al. Activation of beta-catenin signalling by TFF1 loss promotes cell proliferation and gastric tumorigenesis. Gut 2015, 64:1028-1039.
19. Fang D., Hawke D., Zheng Y., Xia Y., Meisenhelder J., Nika H., et al. Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J. Biol. Chem 2007, 282:11221-11229.
20. Taurin S., Sandbo N., Yau D.M., Sethakorn N., Dulin N.O. Phosphorylation of beta-catenin by PKA promotes ATP-induced proliferation of vascular smooth muscle cells. Am. J. Physiol. Cell Physiol 2008, 294:C1169-C1174.
21. Iv Santaliz-Ruiz L.E., Xie X., Old M., Teknos T.N., Pan Q. Emerging role of nanog in tumorigenesis and cancer stem cells. Int. J. Cancer 2014, 135:2741-2748.
22. Ibrahim E.E., Babaei-Jadidi R., Saadeddin A., Spencer-Dene B., Hossaini S., Abuzinadah M., et al. Embryonic NANOG activity defines colorectal cancer stem cells and modulates through AP1- and TCF-dependent mechanisms. Stem Cells 2012, 30:2076-2087.
23. Lee S.H., Koo B.S., Kim J.M., Huang S., Rho Y.S., Bae W.J., et al. Wnt/beta-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4. J. Pathol 2014, 234:99-107.
24. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
25. Dahan P., Martinez Gala J., Delmas C., Monferran S., Malric L., Zentkowski D., et al. Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance. Cell Death Dis 2014, 5:e1543.
26. Iki K., Pour P.M. Expression of Oct4, a stem cell marker, in the hamster pancreatic cancer model. Pancreatology 2006, 6:406-413.
27. Chiou S.H., Wang M.L., Chou Y.T., Chen C.J., Hong C.F., Hsieh W.J., et al. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res 2010, 70:10433-10444.
28. Chiou S.H., Yu C.C., Huang C.Y., Lin S.C., Liu C.J., Tsai T.H., et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin. Cancer Res 2008, 14:4085-4095.
29. Hu C.J., Wang B., Tang B., Chen B.J., Xiao Y.F., Qin Y., et al. The FOXM1-induced resistance to oxaliplatin is partially mediated by its novel target gene Mcl-1 in gastric cancer cells. Biochim. Biophys. Acta 1849, 2015:290-299.
30. Han M.E., Jeon T.Y., Hwang S.H., Lee Y.S., Kim H.J., Shim H.E., et al. Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research. Cell. Mol. Life Sci 2011, 68:3589-3605.
31. Barker N., van Es J.H., Kuipers J., Kujala P., van den Born M., Cozijnsen M., et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-1007.
32. Barker N., Huch M., Kujala P., van de Wetering M., Snippert H.J., van Es J.H., et al. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem cell 2010, 6:25-36.
33. Schepers A.G., Snippert H.J., Stange D.E., van den Born M., van Es J.H., van de Wetering M., et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 2012, 337:730-735.
34. Zhang C., Li C., He F., Cai Y., Yang H. Identification of CD44+CD24+ gastric cancer stem cells. J. Cancer Res. Clin. Oncol 2011, 137:1679-1686.
35. Zhang X., Hua R., Wang X., Huang M., Gan L., Wu Z., et al. Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer. Oncotarget 2016, 10.18632/oncotarget.6890.
36. Bessede E., Staedel C., Acuna Amador L.A., Nguyen P.H., Chambonnier L., Hatakeyama M., et al. Helicobacter pylori generates cells with cancer stem cell properties via epithelial-mesenchymal transition-like changes. Oncogene 2014, 33:4123-4131.
37. Su Y.J., Lin W.H., Chang Y.W., Wei K.C., Liang C.L., Chen S.C., et al. Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3beta/beta-catenin signaling required for maintenance of cancer stem cell properties. Oncotarget 2015, 6:38029-38045.
38. Shan J., Shen J., Liu L., Xia F., Xu C., Duan G., et al. Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma. Hepatology 2012, 56:1004-1014.
39. White B.D., Chien A.J., Dawson D.W. Dysregulation of Wnt/beta-catenin signaling in gastrointestinal cancers. Gastroenterology 2012, 142:219-232.
40. Franco A.T., Israel D.A., Washington M.K., Krishna U., Fox J.G., Rogers A.B., et al. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:10646-10651.
41. van Veelen W., Le N.H., Helvensteijn W., Blonden L., Theeuwes M., Bakker E.R., et al. beta-catenin tyrosine 654 phosphorylation increases Wnt signalling and intestinal tumorigenesis. Gut 2011, 60:1204-1212.
42. Li J., Li J.Y., Chen B.B. Oct4 was a novel target of Wnt signaling pathway. Mol. Cell. Biochem 2012, 362:233-240.
43. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
44. Choi Y.J., Kim N., Chang H., Lee H.S., Park S.M., Park J.H., et al. Helicobacter pylori-induced epithelial-mesenchymal transition, a potential role of gastric cancer initiation and an emergence of stem cells. Carcinogenesis 2015, 36:553-563.
45. Sigal M., Rothenberg M.E., Logan C.Y., Lee J.Y., Honaker R.W., Cooper R.L., et al. Helicobacter pylori activates and expands Lgr5(+) stem cells through direct colonization of the gastric glands. Gastroenterology 2015, 148:1392-1404. e1321.
46. Yin Y., Grabowska A.M., Clarke P.A., Whelband E., Robinson K., Argent R.H., et al. Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7. Gut 2010, 59:1037-1045.
47. Watanabe T., Takahashi A., Suzuki K., Kurusu-Kanno M., Yamaguchi K., Fujiki H., et al. Epithelial-mesenchymal transition in human gastric cancer cell lines induced by TNF-alpha-inducing protein of Helicobacter pylori. Int. J. Cancer 2014, 134:2373-2382.
48. Yu H., Zeng J., Liang X., Wang W., Zhou Y., Sun Y., et al. Helicobacter pylori promotes epithelial-mesenchymal transition in gastric cancer by downregulating programmed cell death protein 4 (PDCD4). PLoS ONE 2014, 9:e105306.
49. Mao J., Fan S., Ma W., Fan P., Wang B., Zhang J., et al. Roles of Wnt/beta-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment. Cell Death Dis 2014, 5:e1039.
50. Jang G.B., Kim J.Y., Cho S.D., Park K.S., Jung J.Y., Lee H.Y., et al. Blockade of Wnt/beta-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype. Sci. Rep 2015, 5:12465.
51. Lee E., Yang J., Ku M., Kim N.H., Park Y., Park C.B., et al. Metabolic stress induces a Wnt-dependent cancer stem cell-like state transition. Cell Death Dis 2015, 6:e1805.
52. Suzuki M., Mimuro H., Kiga K., Fukumatsu M., Ishijima N., Morikawa H., et al. Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe 2009, 5:23-34.
53. Koo B.S., Lee S.H., Kim J.M., Huang S., Kim S.H., Rho Y.S., et al. Oct4 is a critical regulator of stemness in head and neck squamous carcinoma cells. Oncogene 2015, 34:2317-2324.
54. Yin X., Zhang B.H., Zheng S.S., Gao D.M., Qiu S.J., Wu W.Z., et al. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling. J. Hematol. Oncol 2015, 8:23.